Gossamer Bio Inc.
GOSS | NASDAQ
$11.28
+$0.55 (+5.13%)
At close: Sep 21, 2026, 4:00 PM ET
$11.49
+$0.21 (+1.86%)
Pre-market:
Sep 22, 2026, 6:56 AM ET
Market Data
Market Cap $65.57M
Enterprise Value $51M
Beta 2.00
Average Volume 3.94M
Shares Outstanding (Diluted) 234.14M
Shares Change YoY 3.02%
Institutional Ownership 79.24%
Exchange NASDAQ
ISIN US38341P1021
Price Performance
Price Change 1M -6.0%
Price Change 3M -17.7%
Price Change 6M -63.0%
Price Change YTD -95.1%
Price Change 1Y -95.5%
Price Change 3Y -82.4%
Price Change 5Y -98.8%
1M CAGR (ann.) -24.8%
1Y CAGR (ann.) -95.5%
5Y CAGR (ann.) -57.8%
All-Time CAGR -47.4%
Valuation
PE Ratio -16.11
Forward PE N/A
PEG Ratio 0.08
Forward PEG 0.01
PS Ratio 1.29
Forward PS 3.40
PB Ratio -0.73
P/FCF Ratio -0.42
P/Adj. FCF Ratio -0.39
P/OCF Ratio -0.19
EV/Sales 0.96
EV/EBIT -0.25
EV/EBITDA -0.25
EV/FCF -0.31
Earnings Yield -6.2%
FCF Yield -235.9%
Adj. FCF Yield -256.7%
Financial Health
Net Cash $20.88M
Total Debt $39.1M
Cash & Short-Term Investments $57.03M
Total Assets $76.87M
Current Ratio 0.53
Quick Ratio 0.53
Debt / Equity Ratio -0.42
Debt / EBITDA -0.19
Debt / FCF -0.24
OCF / Debt -4.16
Interest Coverage -15.16
Altman Z-Score -35.66
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 99.6%
Operating Profit Margin -311.7%
EBITDA Margin -384.7%
Net Profit Margin -235.0%
FCF Margin -305.2%
Adj. FCF Margin -332.1%
SBC / Revenue 26.9%
SBC Impact (per share) -8.8%
Returns
Return on Assets -162.9%
Return on Equity 108.8%
Return on Invested Capital 670.0%
Return on Capital Employed 272.7%
Return on Tangible Assets -162.9%
Historical Growth (CAGR)
Revenue CAGR 3Y -33.7%
Revenue CAGR 5Y 38.8%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -26.2%
EPS CAGR 5Y 45.6%
EPS CAGR 10Y N/A
FCF CAGR 3Y -74.2%
FCF CAGR 5Y 5.0%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 17
EPS Growth Next 3Y 80.7%
Revenue Growth Next 3Y 48.9%
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $3.47
Price Target Upside -69.2%
Cash Flow
Operating Cash Flow $-162.63M
Free Cash Flow $-162.63M
Adj. Free Cash Flow $-176.96M
FCF Per Share -$58.93
OCF Per Share -$58.93
OCF/S Ratio -305.2%
Income Statement
Revenue $53.29M
Gross Profit $53.05M
Operating Income $-166.09M
EBITDA $-204.98M
Net Income $-125.22M
EPS (Diluted) -$0.70
Revenue / Employee $370.04K
Profit / Employee $-869.6K
Employees 144
Add to Watchlist
Select watchlists to add or remove GOSS